December 23, 2025

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Deep Dive into Its 87% Potential Upside

Investors tracking the biotechnology sector may want to pay close attention to Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company dedicated to advancing treatment options for..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech with 57% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its promising pipeline and substantial upside potential. Operating in the dynamic biotechnology sector, this..

NewAmsterdam Pharma (NAMS) Stock Analysis: Biotech Giant with 31% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a key player in the healthcare sector with a specialization in biotechnology, has been making waves in the investment world...

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 13.38% Upside Potential Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, is renowned for its innovative dental solutions and equipment. With a market capitalization of..

Novavax, Inc. (NVAX) Stock Analysis: Unveiling an 85% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) stands out as a company with intriguing potential despite recent challenges. With a market capitalization of..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 72% Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) is drawing investor attention with its promising growth prospects in the healthcare sector. As a commercial-stage biopharmaceutical company, Dynavax is focused..

Harrow, Inc. (HROW) Stock Analysis: Healthcare Potential with 43% Upside

Harrow, Inc. (NASDAQ: HROW), a Nashville-based eyecare pharmaceutical company, has been making waves in the healthcare sector, with a particular focus on ophthalmic pharmaceutical products. The..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 7.46% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a significant player in the U.S. healthcare sector, operates within the medical care facilities industry. With a market capitalization of..

Vericel Corporation (VCEL) Stock Analysis: A 47% Upside Potential Beckons Investors

Vericel Corporation (NASDAQ: VCEL) presents an intriguing opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $1.89 billion, this biotechnology firm..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 62.58% Upside Potential

Investors with a keen eye on the healthcare sector, particularly the biotechnology industry, may find Innoviva, Inc. (NASDAQ: INVA) a compelling opportunity. This U.S.-based company, with..

Organon & Co. (OGN) Stock Analysis: Exploring the 34% Potential Upside Amidst a Mixed Market Sentiment

For investors keen on healthcare stocks, Organon & Co. (NYSE: OGN) presents a fascinating case. This pharmaceutical company, with a market cap of $1.81 billion, operates..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14.2% Potential Upside in Specialty Pharmaceuticals

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a notable player in the healthcare sector, specializing in non-opioid pain management solutions. Headquartered in Tampa, Florida, the company..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unveiling a 170% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, specializes in developing innovative treatments for rare diseases. With a market capitalization of $1.6..

MannKind Corporation (MNKD) Stock Analysis: A Biotech with 60% Upside Potential

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is garnering significant attention from investors due to its promising growth prospects. With a market..

AtriCure, Inc. (ATRC) Investor Outlook: Evaluating a 25.65% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (ATRC), a prominent player in the medical instruments and supplies industry, is capturing attention with its strong growth metrics and compelling analyst ratings. Headquartered..

LivaNova PLC (LIVN) Stock Analysis: Exploring a Robust 12% Potential Upside in the Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find LivaNova PLC (NASDAQ: LIVN) an intriguing prospect. This UK-based medical device company, with a market capitalization of..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 21.91% Upside with Strong Buy Ratings

Investors seeking opportunities in the healthcare sector may find ICU Medical, Inc. (NASDAQ: ICUI) a compelling choice, given its robust potential upside and solid analyst ratings...

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Revenue Growth

U.S. Physical Therapy, Inc. (NYSE: USPH) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, this..

Phreesia, Inc. (PHR) Stock Analysis: A Potential 81% Upside with Strong Buy Consensus

Phreesia, Inc. (PHR) is making waves in the healthcare sector, specifically within the health information services industry. With a market capitalization nearing the billion-dollar mark at..

Search

Funds

December 23, 2025

Search

Funds

December 23, 2025

FTSE 100

Funds